ProAxsis Evaluates Point-of-Use Test for COPD Exacerbations in New Study
The 21-month clinical research study with Imperial College London will assess the diagnostic value of a lateral flow test for active neutrophil elastase.
The 21-month clinical research study with Imperial College London will assess the diagnostic value of a lateral flow test for active neutrophil elastase.
University of Pittsburgh researchers develop a microneedle array sensor that delivers results in 10 minutes to tell if flu/COVID vaccines are effective.
electronRx announced it will launch purpleDx, a smartphone app for cardiopulmonary assessment, at CES 2025.
Roche’s cobas liat COVID, Influenza A/B & RSV test, is a rapid RT-PCR assay that detects multiple respiratory viruses from a single sample.
Read MoreResearchers have developed an advanced electrostatic air sampler that enhances rapid detection of airborne influenza and coronavirus.
Read MoreQIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MoreADLM’s new guidance on clinical testing for respiratory viral infections emphasizes the use of advanced diagnostic methods and sample types.
Read MoreResearchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Read MoreEvidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MoreA parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreNew data provides a unique snapshot of the interplay among SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).
Read MoreSAS and the Texas DSHS are teaming up on new public health dashboards powered by SAS Viya for tracking influenza data across the state.
Read MoreSekisui Diagnostics’ OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Read MoreHologic Inc. announced that the FDA has granted 510(k) clearance for the company’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay.
Read MoreCue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read MoreScientists report using a nanomaterials-based sensor that can detect the presence of the viruses that cause COVID-19 and the flu.
Read MoreBD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Read More